Dein Suchergebnis zum Thema: Link

An international group of astronomers, led by Juan Diego Soler of the Max Planck Institute for Astronomy, have found a complex network of filamentary structures of atomic hydrogen gas that pervades the Milky Way. They made this intricate web of gas visible by applying techniques from machine vision to THOR survey data that provides the most detailed view on the distribution of atomic hydrogen in the inner Milky Way to date. The scientists analysed the filaments’ orientations relative to the Milky Way disk using statistical methods and simulations. They inferred that the structure conserved an imprint of historic dynamical processes induced by the rotation of the galactic disk and feedback from ancient supernova explosions.
The results and analysis tools from this study offer a new link between the observations

Neurons adjust their synapses by altering the synthesis of hundreds of proteins to regulate synaptic strength and network activity
including schizophrenia, epilepsy, and Parkinson’s disease – thus establishing a direct link

Neurons adjust their synapses by altering the synthesis of hundreds of proteins to regulate synaptic strength and network activity
including schizophrenia, epilepsy, and Parkinson’s disease – thus establishing a direct link

Die Lead Discovery Center GmbH (LDC) und der südkoreanische Arzneimittel-Entwickler Qurient haben in enger Kooperation mit weiteren Partnern die QLi5 Therapeutics GmbH gegründet. Die Partner sind die Max-Planck-Gesellschaft (MPG) und der Nobelpreisträger Prof. Huber, emeritierter Direktor des Max-Planck-Instituts für Biochemie. Die in Dortmund ansässige QLi5 Therapeutics hat neue Proteasom-Inhibitoren vom LDC und seinen Partnern lizenziert, um sie in die präklinische und klinische Prüfung voranzubringen und für die Behandlung von Krebs-, Entzündungs- und Autoimmunerkrankungen zu entwickeln.
Die gemeinsame Gründung von Qurient lief sehr zügig und konstruktiv“, so Dieter Link

Die Lead Discovery Center GmbH (LDC) und der südkoreanische Arzneimittel-Entwickler Qurient haben in enger Kooperation mit weiteren Partnern die QLi5 Therapeutics GmbH gegründet. Die Partner sind die Max-Planck-Gesellschaft (MPG) und der Nobelpreisträger Prof. Huber, emeritierter Direktor des Max-Planck-Instituts für Biochemie. Die in Dortmund ansässige QLi5 Therapeutics hat neue Proteasom-Inhibitoren vom LDC und seinen Partnern lizenziert, um sie in die präklinische und klinische Prüfung voranzubringen und für die Behandlung von Krebs-, Entzündungs- und Autoimmunerkrankungen zu entwickeln.
Die gemeinsame Gründung von Qurient lief sehr zügig und konstruktiv“, so Dieter Link

The causative agent of African sleeping sickness, annually responsible for several thousands of deaths in Africa and South America, is a motile cell: it propels itself through its host’s bloodstream until – in the last stage of the disease – it overcomes the blood-brain-barrier and penetrates its victim’s brain. In order to fight this deadly disease, scientists are trying to understand the parasite’s exact patterns of movement. Researchers from the Max Planck Institute for Dynamics and Self-Organization (MPIDS) in Germany as well as from the Universities of Würzburg, Göttingen and Basel have now succeeded in identifying three different swimming modes. In addition, they were able to show for the first time, that these swimming modes correspond to the shape and stiffness of the parasite.
complicated “physique”: The flagellum, most probably the cell’s main motor, does not link

Eleni Dovrou, postdoctoral fellow at the Max Planck Institute for Chemistry, about the early female climate science pioneer Eunice Newton Foote.
Planck Institute for Chemistry, about Eunice Newton Foote, the first person to link

Scientists publish the first RNA interactome of the human nucleus
“By identifying the protein factors that link RNA to the DNA damage response, this

Three female and nine male scientists from Institutes of the Max Planck Society will each receive up to 1.5 million euros for their research projects.
Polymer Research Tim Lämmermann, MPI of Immunobiology and Epigenetics Hannes Link

Drei Wissenschaftlerinnen und zehn Wissenschaftler aus Instituten der Max-Planck-Gesellschaft erhalten für ihre Forschungsprojekte jeweils bis zu 1,5 Millionen Euro.
, Mainz Tim Lämmermann, MPI für Immunbiologie und Epigenetik, Freiburg Hannes Link